So, do we really know: What is a comprehensive #cancer centre? What should we expect them to be, to do, & to do for & with others? Check out Part II of our work: mdpi.com/2072-6694/17/6/1023 @theNCI @uicc @COSAoncology @EuropeanCancer @myESMO @ASCO @CancerCareMASCC @CancerAustralia

Flinders University researchers have developed a breakthrough drug treatment for sleep apnoea that could gain US approval next year, offering hope to more than one million Australians 😴 📌 READ MORE: bit.ly/4eRXqcu

Powerful talk by @DrN_CancerPCP on patients living with advanced/metastatic cancer ➡️ 1 in 2 face financial toxicity ➡️ 1 in 3 psychological distress ➡️ 1 in 4 physical/daily living challenges Yet many feel “invisible” in survivorship care. Time to rethink the model

@DrN_CancerPCP highlighted @CancerCareMASCC @ASCO guideline on survivorship care for people w advanced/metastatic cancer: 🔹 Routine, longitudinal needs assessment 🔹 Multidisciplinary, coordinated care 🔹 Inclusion of caregivers 🔹 Focus on quality of life across the trajectory

Early bird pricing ends for #ONSCongress on 3/26! Register now to keep up to date w/ @oncologynursing education, networking & the energy that sets the tone for the year ahead 💙🧡!! ons.org/education-hub/events…

Nurse practitioners can now issue cause-of-death certificates and witness non-written health directions in the ACT. ACN calls on other jurisdictions to follow suit, and remove all unnecessary barriers preventing NPs from delivering holistic care #NursesAreTheSolution

A new research article from Shirley SW Tse, Henry CY Wong and colleagues looks at the cost-effectiveness of Mepitel Film for prevention of acute radiation dermatitis (ARD) in breast cancer, from a Canadian healthcare payer’s perspective. Read more here: link.springer.com/article/10…

For World Cancer Day, COSA and CNSA have released a joint position statement on the contribution of nurses to cancer survivorship care in Australia, with recommendations for strengthening survivorship care nationally. Read more bit.ly/4rpF3yD bit.ly/3M83qSk

On #WorldCancerDay we launch our joint @COSAoncology and @CNSA_ORG position statement on the vital contribution of nurses to cancer survivorship care: lnkd.in/gK9FRTwd This statement recognises nurses as central to coordinated, equitable, accessible person-centred care.

🌟 We care about equity in survivorship care for all. 🌟 We work together so people can live well with & beyond cancer. This #WorldCancerDay, we stand #UnitedByUnique — placing people at the heart of care. #CancerSurvivorship #ResearchThatMatters #FlindersCancerSurvivorship

Researchers have found that repurposing a safe and affordable blood pressure medication may help prevent cancer-related cognitive impairment. NeuRA (Neuroscience Research Australia) PhD candidate, Delyse McCaffrey, led the study, ​‘Candesartan, an angiotensin receptor blocker, prevents cognitive impairment in female mice with mammary cancer’, which was published in @BrainBehavImm . “Up to 75% of cancer patients report cognitive symptoms, with around 30% experiencing persistent deficits that interfere with daily functioning and quality of life,” Ms McCaffrey said. “This can impact a person’s ability to think, learn, remember, or make decisions. Despite the profound economic and psychosocial burden, there are limited therapeutic options. "Cancer-related cognitive impairment is associated with a combination of factors, including neuroinflammation, oxidative stress, and blood-brain barrier dysfunction, with evidence suggesting dysregulation of the renin-angiotensin system (RAS), which modulates these processes. “A key advantage of candesartan is its ability to cross the blood – brain barrier and modulate neurobiological processes linked to cognitive decline in cancer, making it an attractive candidate for repurposing to prevent cancer-related cognitive impairment,” Dr Walker said. She worked alongside her supervisors Dr Adam K. Walker and Professor Cynthia Shannon Weickert, and in collaboration with Professor @rayychan at @Flinders University and Professor Janette Vardy @VardyJanette at the @Sydney_Uni. You can read the full article here - neura.edu.au/news-media/medi… You can read the study here - sciencedirect.com/science/ar…

Our first article for 2026 - planning for ‘when’ and not ‘if’ we get cancer - through building accessible and high-quality survivorship care systems. Our analysis and call to action: authors.elsevier.com/a/1mNds…

A new Clinical Practice Statement is now available from our Oncodermatology Study Group on the prevention and management of acute radiation dermatitis with Mepitel Film and Hydrofilm: link.springer.com/article/10… #SuppOnc

In this MASCC Short Talk, @rayychan shares some key highlights of the work presented at #MASCC25 around patient navigation. Watch now: vimeo.com/1138959256?share=c… #SuppOnc

Don’t forget to submit your abstracts for #MASCC26! Visit our website to learn more, and be sure to get your abstract in by January 16 (or December 17 if you plan to apply for a Conference Scholarship). mascc.org/annualmeeting2026/… #SuppOnc #SurvOnc #GlobOnc #PallOnc #Oncology

Geriatric assessment in older adults with cancer: A global scoping review of barriers and strategies to implementation geriatriconcology.net/articl… via @chitchadkitchen et al @lucypgeridoc @drol007

Geriatric assessment in older adults with cancer: A global scoping review of barriers and strategies to implementation geriatriconcology.net/articl… @chitchadkitchen @rayychan @WilliamDale_MD @myCARG #GeriOnc #OlderAdults #OncoAlert #SIOG #YoungSIOG #Elsevier

🚨 New #OpenAccess article! We mapped the global maze of #GeriatricAssessment in #CancerCare 🧓👵 🔍 27 barriers & 17 strategies to GA implementation ✅ Telehealth, nurse-led models, policy advocacy & more 🛠️ Tool template upcoming #DelphiStudy Read here 👉 lnkd.in/gzfFqX4m #GeriatricOncology #ImplementationScience #JGO #ResearchImpact 🙏 With @WilliamDale_MD, @rayychan, Seyi Agbejule, @LKasherman, Catherine Paterson, @AnnaMislang, @martine_puts, @kristenhaase, Jolyn Johal @survonc

I was rejected by the Hong Kong educational system when I was 16. My score didn’t make the cut off to proceed to A-level (UK system). I then pursued education in Australia which changed my life #TweetYourRejection #medTwitter @CancerCareMASCC @fumikochino

Pleased to have @COSAoncology endorsement of the @CancerCareMASCC and @ASCO Standards and Practice Recommendations for Advanced or Metastatic Cancer Survivorship Care: onlinelibrary.wiley.com/doi/…. In this editorial, we offer implementation and future optimal care considerations.

Congratulations to all new Supportive Care 2030 Movement Fellows @CancerCareMASCC #cancer #survonc #supponc